Linked Life Data

10652257

Source:http://linkedlifedata.com/resource/pubmed/id/10652257

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10652257rdf:typepubmed:Citationlld:pubmed
pubmed-article:10652257lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0010853lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0016026lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0031670lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0031672lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0041485lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C0031669lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:10652257lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:10652257pubmed:dateCreated2000-4-12lld:pubmed
pubmed-article:10652257pubmed:abstractTextFibroblast growth factor-mediated signalling was studied in porcine aortic endothelial cells expressing either wild-type fibroblast growth factor receptor-1 or a mutant receptor (Y766F) unable to bind phospholipase C-(&ggr;). Stimulation of cells expressing the wild-type receptor resulted in activation of phospholipases C, D and A(2) and increased phosphoinositide 3-kinase activity. Stimulation of the wild-type receptor also resulted in stress fibre formation and a cellular shape change. Cells expressing the Y766F mutant receptor failed to stimulate phospholipase C, D and A(2) as well as phosphoinositide 3-kinase. Furthermore, no stress fibre formation or shape change was observed. Both the wild-type and Y766F receptor mutant activated MAP kinase and elicited proliferative responses in the porcine aortic endothelial cells. Thus, fibroblast growth factor receptor-1 mediated activation of phospholipases C, D and A(2) and phosphoinositide 3-kinase was dependent on tyrosine 766. Furthermore, whilst tyrosine 766 was not required for a proliferative response, it was required for fibroblast growth factor receptor-1 mediated cytoskeletal reorganisation.lld:pubmed
pubmed-article:10652257pubmed:languageenglld:pubmed
pubmed-article:10652257pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:citationSubsetIMlld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652257pubmed:statusMEDLINElld:pubmed
pubmed-article:10652257pubmed:monthFeblld:pubmed
pubmed-article:10652257pubmed:issn0021-9533lld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:RobertsSSlld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:WakelamM JMJlld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:CrossM JMJlld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:Claesson-Wels...lld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:LandgrenEElld:pubmed
pubmed-article:10652257pubmed:authorpubmed-author:HodgkinM NMNlld:pubmed
pubmed-article:10652257pubmed:issnTypePrintlld:pubmed
pubmed-article:10652257pubmed:volume113 ( Pt 4)lld:pubmed
pubmed-article:10652257pubmed:ownerNLMlld:pubmed
pubmed-article:10652257pubmed:authorsCompleteYlld:pubmed
pubmed-article:10652257pubmed:pagination643-51lld:pubmed
pubmed-article:10652257pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:meshHeadingpubmed-meshheading:10652257...lld:pubmed
pubmed-article:10652257pubmed:year2000lld:pubmed
pubmed-article:10652257pubmed:articleTitleTyrosine 766 in the fibroblast growth factor receptor-1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells.lld:pubmed
pubmed-article:10652257pubmed:affiliationDepartment of Genetics, Rudbeck Laboratory, S-75185 Uppsala, Sweden. michael.cross@genpat.uu.selld:pubmed
pubmed-article:10652257pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10652257pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5335entrezgene:pubmedpubmed-article:10652257lld:entrezgene
entrez-gene:2261entrezgene:pubmedpubmed-article:10652257lld:entrezgene
entrez-gene:9965entrezgene:pubmedpubmed-article:10652257lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652257lld:pubmed